as on January 28, 2026 at 9:40 pm IST
Day's Low
Day's High
1.73%
Downside
4.07%
Upside
52 Week's Low
52 Week's High
88.13%
Downside
25.93%
Upside
Check Corvus Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.9B
EPS (TTM)
-0.16
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-38.8M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-35.82%
Compare market cap, revenue, PE, and other key metrics of Corvus Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.9B | 498.37% | NA | 0.00% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Corvus Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Corvus Pharmaceuticals Inc investment value today
Current value as on today
₹4,27,234
Returns
₹3,27,234
(+327.23%)
Returns from Corvus Pharmaceuticals Inc Stock
₹3,21,260 (+321.26%)
Dollar Returns*
₹5,974 (+5.97%)
Based on 10 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Corvus Pharmaceuticals Inc. Average target price of $28.83
Get share price movements and forecasts by analysts on Corvus Pharmaceuticals Inc.
What analysts predicted
25.77%UPSIDE
Target Price
$28.83
Current Price
$21.4
Analyzed by
10 Analysts
Target
$28.83
Corvus Pharmaceuticals Inc target price $28.83, a slight upside of 25.77% compared to current price of $21.4. According to 10 analysts rating.
Investment in Corvus Pharmaceuticals Inc Shares on INDmoney has grown by 6633.33% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:6633.33% versus previous 30 day period
Search interest for Corvus Pharmaceuticals Inc Stock has increased by 985% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:985% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 20 January
Wed, 00:30 AM
-Corvus Pharmaceuticals shares surged 140% after positive Phase 1 trial results for soquelitinib in atopic dermatitis.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, CRVS has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 1 month, CRVS stock has moved up by 186.8%
Best in 1 Year
![]()
In the last 1 year, CRVS has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Corvus Pharmaceuticals Inc |
| Headquarters | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Dr. Richard A. Miller M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Richard A. Miller M.D. | Co-Founder, President, CEO & Chairman of the Board |
Dr. Peter A. Thompson FACP, M.D. | Co-Founder & Independent Director |
Mr. Leiv Lea | Chief Financial Officer |
Dr. William Benton Jones Ph.D. | Senior Vice President of Pharmaceutical Development |
Mr. Jeffrey S. Arcara | Senior VP & Chief Business Officer |
Corvus Pharmaceuticals Inc share price today is $21.4 as on . Corvus Pharmaceuticals Inc share today touched a day high of $22.27 and a low of $21.03.
Corvus Pharmaceuticals Inc share touched a 52 week high of $26.95 on and a 52 week low of $2.54 on . Corvus Pharmaceuticals Inc stock price today i.e. is trending at $21.4,which is 20.59% down from its 52 week high and 742.52% up from its 52 week low.
Corvus Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Corvus Pharmaceuticals Inc (CRVS) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Corvus Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Corvus Pharmaceuticals Inc share’s latest price of $21.4 as on January 28, 2026 at 9:40 pm IST, you will get 0.4673 shares of Corvus Pharmaceuticals Inc. Learn more about
fractional shares .
Corvus Pharmaceuticals Inc stock has given 498.37% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?